Further, traditional tumor biomarkers like Neuron-Specific Enolase (NSE), Cytokeratin 19 Fragment (CYFRA21-1) and Carcinoembryonic Antigen (CEA) have no desired specificity and sensitivity4,5. The gene discussed is ENO2; the disease is neoplasm.